Literature DB >> 8816380

B cell responses to a peptide epitope. I. The cellular basis for restricted recognition.

A Agarwal1, S Sarkar, C Nazabal, G Balasundaram, K V Rao.   

Abstract

Primary humoral responses in BALB/c mice to a variety of peptide constructs containing a common 15-amino acid residue antigenic determinant (PS1) in conjunction with one or more Th cell epitopes were examined. In all cases, the mature IgG response was found to focus primarily on a tetrapeptide sequence, Asp-Pro-Ala-Phe. The dominance of this segment was independent of the position of the PS1 determinant in the peptide sequence and was also observed in constructs with a random secondary structure. In contrast to the mature IgG response, the early primary IgM response was constituted by multiple specificities that collectively spanned a major proportion of the PS1 sequence. However, subsequent progression of this response entailed a strict selection for only those Abs directed against the Asp-Pro-Ala-Phe segment and apparently occurred at or around the time of the IgM to IgG class switch. Studies of murine responses to peptide analogs containing single amino acid substitutions within the Asp-Pro-Ala-Phe sequence revealed that emergence of this segment as the dominant epitope was a consequence of active suppression of B cells directed against alternate determinants. Positive selection of this subset of Abs correlated with overall higher avidity for epitope binding and was the outcome of a competitive process enforced by the limiting amounts of Th cell help available in the early stages of the primary response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816380

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  B-cell responses to a peptide epitope: mutations in heavy chain alone lead to maturation of antibody responses.

Authors:  R Tuteja
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 2.  The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Authors:  Marinieve Montero; Nienke E van Houten; Xin Wang; Jamie K Scott
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 11.056

3.  Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.

Authors:  Nienke E van Houten; Kevin A Henry; George P Smith; Jamie K Scott
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

4.  Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.

Authors:  N E van Houten; M B Zwick; A Menendez; J K Scott
Journal:  Vaccine       Date:  2006-01-11       Impact factor: 3.641

5.  FcRn overexpression in transgenic mice results in augmented APC activity and robust immune response with increased diversity of induced antibodies.

Authors:  Attila Végh; Anita Farkas; Dorottya Kövesdi; Krisztián Papp; Judit Cervenak; Zita Schneider; Balázs Bender; László Hiripi; Glória László; József Prechl; János Matkó; Imre Kacskovics
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

6.  FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice.

Authors:  Bence Szikora; Anita Marx; Péter K Jani; Orsolya Pipek; Viktor Müller; István Csabai; Imre Kacskovics
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

7.  Vaccinia and other viruses with available vaccines show marked homology with the HIV-1 envelope glycoprotein: the prospect of using existing vaccines to stem the AIDS pandemic.

Authors:  C J Chris Carter
Journal:  Immunopharmacol Immunotoxicol       Date:  2011-08-19       Impact factor: 3.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.